Product NDC: | 68382-036 |
Proprietary Name: | venlafaxine hydrochloride |
Non Proprietary Name: | venlafaxine hydrochloride |
Active Ingredient(s): | 150 mg/1 & nbsp; venlafaxine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68382-036 |
Labeler Name: | Zydus Pharmaceuticals (USA) Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090174 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110601 |
Package NDC: | 68382-036-16 |
Package Description: | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-036-16) |
NDC Code | 68382-036-16 |
Proprietary Name | venlafaxine hydrochloride |
Package Description | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-036-16) |
Product NDC | 68382-036 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | venlafaxine hydrochloride |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20110601 |
Marketing Category Name | ANDA |
Labeler Name | Zydus Pharmaceuticals (USA) Inc. |
Substance Name | VENLAFAXINE HYDROCHLORIDE |
Strength Number | 150 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |